JORNAY Drug Patent Profile
✉ Email this page to a colleague
When do Jornay patents expire, and what generic alternatives are available?
Jornay is a drug marketed by Ironshore Pharms and is included in one NDA. There are sixteen patents protecting this drug.
The generic ingredient in JORNAY is methylphenidate hydrochloride. There is one drug master file entry for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Jornay
A generic version of JORNAY was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for JORNAY?
- What are the global sales for JORNAY?
- What is Average Wholesale Price for JORNAY?
Summary for JORNAY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for JORNAY |
| DailyMed Link: | JORNAY at DailyMed |
US Patents and Regulatory Information for JORNAY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-005 | Aug 8, 2018 | RX | Yes | Yes | 11,911,518 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-003 | Aug 8, 2018 | RX | Yes | No | 11,241,391 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-002 | Aug 8, 2018 | RX | Yes | No | 10,182,995 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-004 | Aug 8, 2018 | RX | Yes | No | 8,916,588 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-004 | Aug 8, 2018 | RX | Yes | No | 11,241,392 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
